Related Experiment Video
Updated: Mar 2, 2026
05:44
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
2.5K
Genetic modifiers of multiple sclerosis progression, severity and onset
A Dessa Sadovnick1, Anthony L Traboulsee2, Yinshan Zhao2
1Department of Medical Genetics, University of British Columbia, Vancouver, Canada; Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Clinical Immunology (Orlando, Fla.)
|May 15, 2017
Summary
Genetic factors influence multiple sclerosis (MS) clinical outcomes. Specific gene variants like PSMG4 and NLRP5 are linked to MS severity and disease progression, offering insights into personalized MS treatment strategies.
Area of Science:
- Genetics
- Neurology
- Immunology
Background:
- The genetic underpinnings of multiple sclerosis (MS) clinical variability remain largely unexplored.
- Understanding genetic influences is crucial for predicting disease course and severity.
Purpose of the Study:
- To identify genetic variants associated with distinct clinical phenotypes in multiple sclerosis.
- To explore the relationship between genetic factors and MS disease course, severity, and onset age.
Main Methods:
- Exome sequencing was performed on 100 MS patients with extreme phenotypes (discovery cohort).
- Variants of interest were genotyped in a larger cohort of 2016 MS patients (replication cohort).
- Linear and logistic regression analyses were employed to assess associations with clinical outcomes.
Main Results:
- Thirty-eight variants in 21 genes were nominated in the discovery cohort.
- PSMG4 p.W99R and NLRP5 p.M459I showed significant association with MS disease severity.
- CACNA1H p.R1871Q was linked to relapsing-remitting MS onset, while NLRP5 and EIF2AK1 variants were associated with primary progressive MS.
- PSMG4, NLRP5, and MC1R variants correlated with age at MS onset.
Conclusions:
- Specific genetic variants significantly influence multiple sclerosis clinical outcomes, including disease severity and progression.
- These findings highlight potential genetic biomarkers for predicting MS trajectory.
- Further research into these genetic associations could pave the way for personalized therapeutic strategies in MS management.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
65
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
65
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
01:28Human Genetics
1.8K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K
01:27Principles of Pharmacogenetics: Types of Genetic Variants
60
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
60
01:11Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K